H.B. Fuller Company

FUL • Chemicals - Specialty

$53.89

▲ +0.22 (+0.41%)

Current price

EarningsLatest report: Feb 28, 2026

BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology

Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.

Market Cap

$2.99B

Growth

5.2%

Cash Flow

5/5

Trend

Stable

Evidence

Positive free cash flow · 2.22Consistent free cash flow · 5/5Reasonable earnings multiple · 20.94Healthy liquidity · 1.7Negative growth trend

Financial data as of: Feb 28, 2026, 12:00 AM UTCLast earnings update: Mar 25, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$53.89

Change0.41%

Shares Out55.51M

Market Cap$2.99B

Enterprise Value$4.96B

52W Range48.71 - 68.63

Beta0.96

P/E18.72

P/S0.87

P/B1.45

P/FCF20.57

EV/Sales1.44

Price$53.89

Change0.41%

Shares Out55.51M

Market Cap$2.99B

Enterprise Value$4.96B

52W Range48.71 - 68.63

Beta0.96

P/E18.72

P/S0.87

P/B1.45

P/FCF20.57

EV/Sales1.44

EV/EBITDA10.01

EV/FCF34.10

Earnings Yield5.34%

FCF Yield4.86%

Dividend Yield1.73%

Gross Margin31.69%

Oper. Margin11.49%

Profit Margin4.37%

Debt/Eq1.01

Current Ratio1.70

Quick Ratio1.06

Revenue 5Y5.24%

Target$66.80

Target Upside23.96%

Target Median$67.00

Target Range58.00 - 73.00

Volume458.80K

Avg Volume660.90K

EPS Surprise0.01

Investment DNA

How strong this company looks for long-term investors

out of 100

Business Quality

Margins, moat, returns

49/100

Financial Strength

Debt, cash, stability

64/100

Growth Potential

Revenue and expansion

31/100

Price Attractiveness

Cheap or expensive today

78/100

Why this score▼

Positive free cash flow · 2.22Consistent free cash flow · 5/5Reasonable earnings multiple · 20.94Healthy liquidity · 1.7Negative growth trend

Analyst view

Analyst sentiment and price target

FUL

Analyst sentiment

Based on 15 analyst votes · 2026-09-05

80/100

Bullish

Hold

Bearish

Price Target

2026-06-24

Low

$58.00

Mean

$71.50

Median

$72.00

High

$84.00

Company Overview

IPO: 2/21/1973

Industry: Chemicals - Specialty

P/B i: 1.45

Debt / Equity i: 1.01

Operating Margin: 11.49%

Net Margin: 4.37%

ROE i: -

ROIC: -

Financial Health

Score13 / 20

Debt / Equity: 1.01

Current Ratio: 1.70

Quick Ratio: 1.06

Status: Good

Insider Transactions

Recent executive and insider activity

Campe Heather

Transaction: 06/22/2026

BUY

Change

—

Price

Not reported

Filing

06/23/2026

Type

BUY

Corkrean John J

Transaction: 06/22/2026

BUY

Change

—

Price

Not reported

Filing

06/23/2026

Type

BUY

Campe Heather

Transaction: 06/05/2026

BUY

Change

—

Price

Not reported

Filing

06/08/2026

Type

BUY

Insider	Type	Change	Price	Transaction	Filing
Campe Heather	BUY	—	Not reported	06/22/2026	06/23/2026
Corkrean John J	BUY	—	Not reported	06/22/2026	06/23/2026
Campe Heather	BUY	—	Not reported	06/05/2026	06/08/2026
Corkrean John J	BUY	—	Not reported	06/05/2026	06/08/2026
FLORNESS DANIEL L	BUY	—	Not reported	05/29/2026	06/02/2026
HANDLEY THOMAS W	BUY	—	Not reported	05/29/2026	06/02/2026
Happe Michael J	BUY	—	Not reported	05/29/2026	06/02/2026
Kimmelshue Ruth	BUY	—	Not reported	05/29/2026	06/02/2026
Rasmussen Trangsrud Teresa J	BUY	—	Not reported	05/29/2026	06/02/2026
Campe Heather	BUY	—	Not reported	05/22/2026	05/26/2026
Corkrean John J	BUY	—	Not reported	05/22/2026	05/26/2026
Campe Heather	BUY	—	Not reported	05/08/2026	05/11/2026
Corkrean John J	BUY	—	Not reported	05/08/2026	05/11/2026
Campe Heather	BUY	—	Not reported	04/24/2026	04/27/2026
Corkrean John J	BUY	—	Not reported	04/24/2026	04/27/2026
Rasmussen Trangsrud Teresa J	BUY	+1,000	$65.83	04/17/2026	04/20/2026
Campe Heather	BUY	—	Not reported	04/10/2026	04/14/2026
Corkrean John J	BUY	—	Not reported	04/10/2026	04/14/2026
Mastin Celeste Beeks	BUY	+5,170	$57.08	04/07/2026	04/07/2026
Corkrean John J	BUY	+213	Not reported	03/27/2026	03/30/2026

About the Company

H.B. Fuller Company

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Building Adhesive Solutions. The Hygiene, Health and Consumable Adhesives segment produces and supplies specialty industrial adhesives, such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven and hygiene, and medical and beauty. The Engineering Adhesives segment produces and supplies high performance industrial adhesives comprising reactive, light cure, two-part liquids, polyurethane, silicone, film, and fast cure products to the durable assembly, performance wood and textile, transportation, electronics, clean energy, aerospace and defense, appliance, heavy machinery, and insulating glass markets. The Construction Adhesives segment provides products used for commercial roofing, heating, ventilation, and air conditioning and insulation applications, as well as caulks and sealants for the consumer market and professional trade. The company sells its products directly to customers, as well as through distributors and retailers in North America, Latin America, Europe, India, the Middle East, Africa, and the Asia Pacific. H.B. Fuller Company was founded in 1887 and is headquartered in Saint Paul, Minnesota.

Source - link

Peers

AVNT CBT CENX HWKN OLN PRM SMG SXT USLM WDFC

Size reflects market cap · color matches the chart line

1Y peer performance

Top performers + selected company

Latest news

Should Value Investors Buy H. B. Fuller (FUL) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research

Ancora Reaffirms Offer to Acquire H.B. Fuller's BAS Segment

CLEVELAND--(BUSINESS WIRE)--Ancora Holdings Group LLC (together with its affiliates, “Ancora”), a meaningful shareholder of H.B. Fuller Company (NYSE: FUL) (“H.B. Fuller” or the “Company”), today reaffirmed its proposal to acquire the Company's Building Adhesive Solutions (“BAS”) segment following H.B. Fuller's Board of Directors' (the “Board”) baseless rejection of the offer and issued the following statement: “First and foremost, Ancora reaffirms the offer that it recently submitted, as it is.

Business Wire

FUL or NVZMY: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Chemical - Specialty sector might want to consider either H. B. Fuller (FUL) or Novozymes A/S (NVZMY).

Zacks Investment Research

Here's Why H. B. Fuller (FUL) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research

H.B. Fuller Board Unanimously Rejects Unsolicited Proposal from Ancora

H.B. Fuller Company (âH.B. Fullerâ or âthe Companyâ) (NYSE: FUL), the world's largest pureplay adhesives company, today announced that, following a thor

GuruFocus

Earnings Surprises

Period	Estimate	Actual	Surprise
2026-03-25	0.56	0.57	0.01
2026-01-14	1.24	1.28	0.04
2025-09-24	1.24	1.26	0.02
2025-06-25	1.1	1.18	0.08
2025-03-26	0.4937	0.54	0.0463
2025-01-15	1.24	0.92	-0.32
2024-09-25	1.23	1.13	-0.1
2024-06-26	1.03	1.12	0.09
2024-03-27	0.64	0.67	0.03
2024-01-17	1.29	1.32	0.03
2023-09-27	1.17	1.06	-0.11
2023-06-28	1.04	0.93	-0.11